If you encounter issues logging in with your credentials, please contact our customer services team and we will endeavour to assist as quickly as possible Sponsor deploys Permira VIII to ride new wave ...

The business, which provides wastewater services and products, is expected to be marketed off annual EBITDA in the region of USD 20m, according to one of the sources and a third familiar with the ...

The deal is reportedly worth around €2.5bn, equal to approximately 18x Galileo's EBITDA. CPP invested through its wholly owned subsidiary CPP Investment Board Europe. The consortium also comprises ...

The GP will acquire a 66% stake in the company via its €250m KJK Fund III, which held a final close in January 2020 and is focused on SMEs in the Balkan and Baltic regions. Gediminas Šimkus, the ...

Initial bids for the business were due last week, said one of the sources. Permira already owns Neuraxpharm, a specialty pharma company focused on the treatment of the central nervous system (CNS), ...

TA XV closed on its hard cap, exceeding its initial target size, after launching in November 2022. Few sponsors, especially generalist buyout funds, have been able to close multi-billion funds in the ...

The deal marks the fourth platform acquisition made via the GP's Triton Smaller Mid Cap fund, which held a first close on €150m in June 2017 and aims to raise between €300-500m. Unident is the fund's ...

The deal values the business at around £200m, according to a report in the Daily Telegraph, while Unquote sister publication Mergermarket... , Buyouts, UK / Ireland, Healthcare , United Kingdom, ...

Mak-System also announced the appointment of Philippe Houssiau as CEO following a vote by shareholders. The investment will support the company's growth, including its international expansion, ...

DIF Core Infrastructure Fund I closed on €450m in 2017. The two firms will wholly acquire the company, each taking a 50% stake for an undisclosed sum. The firms have agreed to back Unitank's long-term ...

The transaction is said to value the company at £600-700m, according to Unquote sister publication Mergermarket. Inflexion is currently investing from Inflexion Partnership Capital Fund II, which ...

Y1 owns a portfolio of healthcare services businesses in the UK and Europe, including cosmetic surgery and hair transplant chain Signature Medical. The buying GP's CEO Tony Veverka is the former CEO ...